User: Guest  Login
Title:

Molecular MR Imaging of Prostate Cancer.

Document type:
Journal Article; Review
Author(s):
Kader, Avan; Brangsch, Julia; Kaufmann, Jan O; Zhao, Jing; Mangarova, Dilyana B; Moeckel, Jana; Adams, Lisa C; Sack, Ingolf; Taupitz, Matthias; Hamm, Bernd; Makowski, Marcus R
Abstract:
This review summarizes recent developments regarding molecular imaging markers for magnetic resonance imaging (MRI) of prostate cancer (PCa). Currently, the clinical standard includes MR imaging using unspecific gadolinium-based contrast agents. Specific molecular probes for the diagnosis of PCa could improve the molecular characterization of the tumor in a non-invasive examination. Furthermore, molecular probes could enable targeted therapies to suppress tumor growth or reduce the tumor size.
Journal title abbreviation:
Biomedicines
Year:
2021
Journal volume:
9
Journal issue:
1
Fulltext / DOI:
doi:10.3390/biomedicines9010001
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/33375045
TUM Institution:
Institut für Diagnostische und Interventionelle Radiologie
 BibTeX